An Open-Label Study of Azetukalner in Major Depressive Disorder

NCT06922110 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Azetukalner

Sponsor

Xenon Pharmaceuticals Inc.